The histone acetyltransferase hMOF suppresses hepatocellular carcinoma growth

Biochemical and Biophysical Research Communications

Volumn 452, Issue 3, 2014, Pages 575-580

  Zhang, Jin ^a   Liu, Hui ^a   Pan, Hao ^b   Yang, Yuan ^a   Huang, Gang ^a   Yang, Yun ^a   Zhou, Wei Ping ^a   Pan, Ze Ya ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Hepatocellular carcinoma; hMOF; SIRT6

Indexed keywords

HISTONE ACETYLTRANSFERASE; MALES ABSENT ON THE FIRST; SIRTUIN 6; UNCLASSIFIED DRUG; KAT8 PROTEIN, HUMAN; SIRT6 PROTEIN, HUMAN; SIRTUIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; ANIMAL; CANCER TRANSPLANTATION; CASE CONTROL STUDY; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; LIVER; LIVER TUMOR; METABOLISM; MORTALITY; PATHOLOGY; SIGNAL TRANSDUCTION; SURVIVAL; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE ACETYLTRANSFERASES; HUMANS; LIVER; LIVER NEOPLASMS; MICE; NEOPLASM TRANSPLANTATION; SIGNAL TRANSDUCTION; SIRTUINS; SURVIVAL ANALYSIS; TUMOR BURDEN;

EID: 84907560467     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.08.122     Document Type: Article

References (26)

1. P.A. Farazi, and R.A. DePinho Hepatocellular carcinoma pathogenesis: from genes to environment Nat. Rev. Cancer 6 2006 674 687
2. R.T. Poon Prevention of recurrence after resection of hepatocellular carcinoma: a daunting challenge Hepatology 54 2011 757 759
3. A. Gupta, T.G. Guerin-Peyrou, G.G. Sharma, C. Park, M. Agarwal, R.K. Ganju, S. Pandita, K. Choi, S. Sukumar, R.K. Pandita, T. Ludwig, and T.K. Pandita The mammalian ortholog of Drosophila MOF that acetylates histone H4 lysine 16 is essential for embryogenesis and oncogenesis Mol. Cell. Biol. 28 2008 397 409
4. P. Kapoor-Vazirani, J.D. Kagey, and P.M. Vertino SUV420H2-mediated H4K20 trimethylation enforces RNA polymerase II promoter-proximal pausing by blocking hMOF-dependent H4K16 acetylation Mol. Cell. Biol. 31 2011 1594 1609
5. Y. Wang, R. Zhang, D. Wu, Z. Lu, W. Sun, Y. Cai, C. Wang, and J. Jin Epigenetic change in kidney tumor: downregulation of histone acetyltransferase MYST1 in human renal cell carcinoma J. Exp. Clin. Cancer Res. 32 2013 1 8
6. N. Liu, R. Zhang, X. Zhao, J. Su, X. Bian, J. Ni, Y. Yu, Y. Cai, and J. Jin A potential diagnostic marker for ovarian cancer: involvement of the histone acetyltransferase, human males absent on the first Oncol. Lett. 6 2013 393 400
7. S. Pfister, S. Rea, M. Taipale, F. Mendrzyk, B. Straub, C. Ittrich, O. Thuerigen, H.P. Sinn, A. Akhtar, and P. Lichter The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma Int. J. Cancer 122 2008 1207 1213
8. J.S. Song, S.-M. Chun, J.Y. Lee, D.K. Kim, Y.H. Kim, and S.J. Jang The histone acetyltransferase hMOF is overexpressed in non-small cell lung carcinoma Korean J. Pathol. 45 2011 386 396
9. L. Zhao, D.-L. Wang, Y. Liu, S. Chen, and F.-L. Sun Histone acetyltransferase hMOF promotes S phase entry and tumorigenesis in lung cancer Cell. Signal. 25 2013 1689 1698
10. Z. Chen, X. Ye, N. Tang, S. Shen, Z. Li, X. Niu, S. Lu, and L. Xu HMOF acetylates Nrf2 and regulates anti-drug responses in human non-small cell lung caner Br. J. Pharmacol. 171 13 2014 3196 3211
11. L. Cao, L. Zhu, J. Yang, J. Su, J. Ni, Y. Du, D. Liu, Y. Wang, F. Wang, J. Jin, and Y. Cai Correlation of low expression of hMOF with clinicopathological features of colorectal carcinoma, gastric cancer and renal cell carcinoma Int. J. Oncol. 44 2014 1207 1214
12. L. Min, Y. Ji, L. Bakiri, Z. Qiu, J. Cen, X. Chen, L. Chen, H. Scheuch, H. Zheng, L. Qin, K. Zatloukal, L. Hui, and E.F. Wagner Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin Nat. Cell Biol. 14 2012 1203 1211
13. J.U. Marquardt, K. Fischer, K. Baus, A. Kashyap, S. Ma, M. Krupp, M. Linke, A. Teufel, U. Zechner, D. Strand, S.S. Thorgeirsson, P.R. Galle, and S. Strand SIRT6 dependent genetic and epigenetic alterations are associated with poor clinical outcome in HCC patients Hepatology 58 2013 1054 1064
14. E. Erdal, N. Ozturk, T. Cagatay, E. Eksioglu-Demiralp, and M. Ozturk Lithium-mediated downregulation of PKB/Akt and cyclin E with growth inhibition in hepatocellular carcinoma cells Int. J. Cancer 115 2005 903 910
15. S. Wilkening, F. Stahl, and A. Bader Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties Drug Metab. Dispos. 31 2003 1035 1042
16. W. Han, Z. Xin, Z. Zhao, W. Bao, X. Lin, B. Yin, J. Zhao, J. Yuan, B. Qiang, and X. Peng RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3 J. Clin. Investig. 123 2013 2103 2118
17. T. Thomas, M.P. Dixon, A.J. Kueh, and A.K. Voss Mof (MYST1 or KAT8) is essential for progression of embryonic development past the blastocyst stage and required for normal chromatin architecture Mol. Cell. Biol. 28 2008 5093 5105
18. A. Gupta, G.G. Sharma, C.S. Young, M. Agarwal, E.R. Smith, T.T. Paull, J.C. Lucchesi, K.K. Khanna, T. Ludwig, and T.K. Pandita Involvement of human MOF in ATM function Mol. Cell. Biol. 25 2005 5292 5305
19. Y. Dou, T.A. Milne, A.J. Tackett, E.R. Smith, A. Fukuda, J. Wysocka, C.D. Allis, B.T. Chait, J.L. Hess, and R.G. Roeder Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF Cell 121 2005 873 885
20. G.G. Sharma, S. So, A. Gupta, R. Kumar, C. Cayrou, N. Avvakumov, U. Bhadra, R.K. Pandita, M.H. Porteus, D.J. Chen, J. Cote, and T.K. Pandita MOF and histone H4 acetylation at lysine 16 are critical for DNA damage response and double-strand break repair Mol. Cell. Biol. 30 2010 3582 3595
21. X. Li, C.A. Corsa, P.W. Pan, L. Wu, D. Ferguson, X. Yu, J. Min, and Y. Dou MOF and H4 K16 acetylation play important roles in DNA damage repair by modulating recruitment of DNA damage repair protein Mdc1 Mol. Cell. Biol. 30 2010 5335 5347
22. S.M. Sykes, H.S. Mellert, M.A. Holbert, K. Li, R. Marmorstein, W.S. Lane, and S.B. McMahon Acetylation of the p53 DNA-binding domain regulates apoptosis induction Mol. Cell 24 2006 841 851
23. Y. Zhou, K.M. Schmitz, C. Mayer, X. Yuan, A. Akhtar, and I. Grummt Reversible acetylation of the chromatin remodelling complex NoRC is required for non-coding RNA-dependent silencing Nat. Cell Biol. 11 2009 1010 1016
24. H.S. Kim, C. Xiao, R.H. Wang, T. Lahusen, X. Xu, A. Vassilopoulos, G. Vazquez-Ortiz, W.I. Jeong, O. Park, S.H. Ki, B. Gao, and C.X. Deng Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis Cell Metab. 12 2010 224 236
25. C. Xiao, R.H. Wang, T.J. Lahusen, O. Park, A. Bertola, T. Maruyama, D. Reynolds, Q. Chen, X. Xu, H.A. Young, W.J. Chen, B. Gao, and C.X. Deng Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice J. Biol. Chem. 287 2012 41903 41913
26. S.J. Yang, J.M. Choi, S.W. Chae, W.J. Kim, S.E. Park, E.J. Rhee, W.Y. Lee, K.W. Oh, S.W. Park, S.W. Kim, and C.Y. Park Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats PLoS One 6 2011 e17057